ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Ohio » Rheumatology

Top Rheumatology Prescribers in Ohio

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
ISAM DIAB MD

Rheumatology

11,260

$962K

976
752 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$85
Average prescription price

Avg: $160

EDWARD HERZIG M.D.

Rheumatology

10,955

$1.22M

591
466 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$112
Average prescription price

Avg: $160

DAVID MANDEL M.D.

Rheumatology

8,442

$1.58M

792
648 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 22%

$187
Average prescription price

Avg: $160

DAVID STAINBROOK D.O.

Rheumatology

8,257

$3.06M

669
474 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 22%

$370
Average prescription price

Avg: $160

MUJEEB RANGINWALA M.D.

Rheumatology

7,638

$783K

767
565 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

14%
prescriptions for brand name drugs

Avg: 22%

$103
Average prescription price

Avg: $160

RICHARD STEIN MD

Rheumatology

6,937

$840K

491
413 are 65+

14%
patients receiving schedule two controlled substances

Avg: 3%

14%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$121
Average prescription price

Avg: $160

VAN WARREN MD

Rheumatology

6,786

$862K

605
382 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$127
Average prescription price

Avg: $160

GREGORY DELORENZO MD

Rheumatology

6,486

$680K

617
480 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$105
Average prescription price

Avg: $160

RAJESH KATARIA DO

Rheumatology

6,322

$1.05M

505
324 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

15%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 22%

$166
Average prescription price

Avg: $160

DAVID MARTIN M.D.

Rheumatology

5,861

$1.19M

628
507 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 22%

$203
Average prescription price

Avg: $160

ROBERT SCHRIBER MD

Rheumatology

5,833

$960K

438
343 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

8%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$165
Average prescription price

Avg: $160

KEVIN HACKSHAW M.D.

Rheumatology

5,472

$838K

434
201 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$153
Average prescription price

Avg: $160

TERRENCE FOLEY M.D.

Rheumatology

5,316

$363K

422
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$68
Average prescription price

Avg: $160

PADMA VELLANKI M.D.

Rheumatology

5,191

$634K

487
376 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

21%
prescriptions for brand name drugs

Avg: 22%

$122
Average prescription price

Avg: $160

SANFORD WOLFE DO

Rheumatology

5,172

$869K

424
334 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

24%
prescriptions for brand name drugs

Avg: 22%

$168
Average prescription price

Avg: $160

MICHAEL LUZAR M.D.

Rheumatology

4,971

$887K

415
361 are 65+

8%
patients receiving schedule two controlled substances

Avg: 3%

20%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

29%
prescriptions for brand name drugs

Avg: 22%

$178
Average prescription price

Avg: $160

JAMES GIDEON M.D.

Rheumatology

4,913

$478K

404
297 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

17%
patients receiving schedule three controlled substances

Avg: 9%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

13%
prescriptions for brand name drugs

Avg: 22%

$97
Average prescription price

Avg: $160

JANICE GRANIERI MD

Rheumatology

4,907

$510K

423
347 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

16%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

20%
prescriptions for brand name drugs

Avg: 22%

$104
Average prescription price

Avg: $160

VAGESH HAMPOLE MD

Rheumatology

4,725

$616K

322
243 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

7%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$130
Average prescription price

Avg: $160

MICHAEL PORDY M.D.

Rheumatology

4,705

$349K

298
255 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$74
Average prescription price

Avg: $160

LAWRENCE KENT M.D.

Rheumatology

4,663

$401K

319
295 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 9%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

26%
prescriptions for brand name drugs

Avg: 22%

$86
Average prescription price

Avg: $160

MATTHEW MORROW MD

Rheumatology

4,601

$505K

414
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

24%
patients receiving schedule three controlled substances

Avg: 9%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

18%
prescriptions for brand name drugs

Avg: 22%

$110
Average prescription price

Avg: $160

JON RYAN DO

Rheumatology

4,546

$830K

514
357 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

13%
patients receiving schedule three controlled substances

Avg: 9%

5%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

19%
prescriptions for brand name drugs

Avg: 22%

$183
Average prescription price

Avg: $160

SALEM FOAD M D

Rheumatology

4,473

$524K

366
282 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

33%
patients receiving schedule three controlled substances

Avg: 9%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

17%
prescriptions for brand name drugs

Avg: 22%

$117
Average prescription price

Avg: $160

DOUGLAS FLAGG MD

Rheumatology

4,425

$729K

373
336 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 9%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

25%
prescriptions for brand name drugs

Avg: 22%

$165
Average prescription price

Avg: $160

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank